FDA Issues Guidance on PET Radiopharmaceutical Manufacturing Processes

Julie Ritzer Ross | | Radiology Business | Business Intelligence
A final guidance on current good manufacturing practices (cGMPs) for PET radiopharmaceuticals has been issued by the U.S. Food and Drug Administration (FDA). Included in the recommendations—which the agency based in part on information from the U.S. Pharmacopeia (USP) general chapter on PET drug compounding--are guidelines for handling and distributing PET drugs. Guidelines pertaining to labeling and packaging, components and containers, and record keeping are provided as well. The agency recommends that newly installed equipment be qualified before first use to verify that it was installed correctly and can be operated as intended. It also counsels manufacturers to develop a preventive maintenance schedule with sufficient frequency to ensure correct equipment performance. The guidelines also incorporate the recommendations that PET drug production facilities have adequate ongoing programs or plans in place to train employees in new procedures and operations and in areas where deficiencies have occurred. To read the guidance, click here: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM266640.pd.

Julie Ritzer Ross,

Contributor

Related Content

Orano Med breaks ground on $265M thorium production site
Image-interpretation market scoreboard: Radiologists 72%, others 28%
Lantheus lands rights to budding radiopharmaceuticals for initial outlay of $35M
17 short-term strategies to address the national radiologist shortage
‘SR’ onboards another independent practice, its 1st in the Natural State
Analysis: Allied radiology professionals generate millions of dollars per year in indirect revenues alone

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.